Gerrit Dispersyn
2019
In 2019, Gerrit Dispersyn earned a total compensation of $659.4K as President and Chief Executive Officer at RXi Pharmaceuticals, a 55% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,935 |
|---|---|
| Salary | $372,251 |
| Stock Awards | $117,662 |
| Other | $534 |
| Total | $659,382 |
Dispersyn received $372.3K in salary, accounting for 56% of the total pay in 2019.
Dispersyn also received $168.9K in non-equity incentive plan, $117.7K in stock awards and $534 in other compensation.
Rankings
In 2019, Gerrit Dispersyn's compensation ranked 10,916th out of 13,971 executives tracked by ExecPay. In other words, Dispersyn earned more than 21.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,916 out of 13,971 | 22nd |
Division Manufacturing | 4,416 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,727 out of 2,200 | 22nd |
Industry group Drugs | 1,481 out of 1,886 | 22nd |
Industry Pharmaceutical Preparations | 1,092 out of 1,398 | 22nd |
Source: SEC filing on August 28, 2020.
Dispersyn's colleagues
We found two more compensation records of executives who worked with Gerrit Dispersyn at RXi Pharmaceuticals in 2019.